• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, November 20, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Prophylactic Sephin1 Preserves Mouse Visual Circuit Structure and Function in Autoimmune Encephalomyelitis

by
November 20, 2026
in Health
Reading Time: 3 mins read
0
Prophylactic Sephin1 Preserves Mouse Visual Circuit Structure and Function in Autoimmune Encephalomyelitis

Prophylactic Sephin1 Preserves Mouse Visual Circuit Structure and Function in Autoimmune Encephalomyelitis

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

In an animal model of multiple sclerosis, early preventive treatment with the integrated stress response modulator Sephin1 protected visual pathway structure and function during acute inflammatory demyelination. Multiple sclerosis produces extensive inflammatory demyelination, axonal injury, and synaptic pathology that culminate in progressive neurodegeneration across the central nervous system. While Sephin1 has previously been shown to decrease clinical severity and safeguard spinal cord myelin, oligodendrocytes, and axons in experimental autoimmune encephalomyelitis, standard disease scoring primarily reflects motor disability. Consequently, researchers evaluated whether Sephin1 preserves function and architecture within a defined, functionally accessible central nervous system circuit by examining the murine visual pathway.

To investigate circuit-specific therapeutic outcomes, investigators induced experimental autoimmune encephalomyelitis in C57BL/6J mice via immunization with myelin oligodendrocyte glycoprotein peptide 35–55. The experimental design evaluated distinct administration schedules: prophylactic delivery began seven days after induction and continued through peak disease, whereas therapeutic delivery was initiated at the onset of clinical symptoms and continued either through chronic disease or for an isolated seven-day duration. Functional integrity was assessed using recordings of the optomotor response to determine visual acuity, pattern-stimulated visual evoked potentials to capture cortical responses, and pattern electroretinography to evaluate retinal activity. Circuit pathology was evaluated across the retina, optic nerve, and lateral geniculate nucleus through immunohistochemistry alongside RNA in situ hybridization.

Prophylactic administration of Sephin1 successfully reduced overall clinical severity and maintained visual acuity at peak disease. Functional electrophysiological assessments revealed that prophylactic Sephin1 preserved pattern-stimulated visual evoked potential N1 amplitudes, demonstrating maintenance of visually evoked cortical response magnitudes during acute inflammation. In contrast, pattern-stimulated visual evoked potential latency, pattern electroretinography responses, and total retinal ganglion cell counts were not significantly altered at this peak disease stage, indicating that cortical response preservation occurred prior to measurable gross retinal loss.

Histological analyses demonstrated that prophylactic Sephin1 treatment directly preserved optic nerve myelin, oligodendrocytes, and axonal structures. Downstream within the lateral geniculate nucleus, treatment protected retinogeniculate axons and maintained retinal ganglion cell presynaptic terminals. Interestingly, these protective structural and functional outcomes occurred without any detectable reduction in optic nerve CD45-positive immune cell accumulation, CD3-positive T-cell infiltration, reactive astrogliosis, or inflammatory microglial responses, showing that neuroprotection occurred independently of broad immune suppression in the optic nerve tissue.

Molecular evaluations of optic nerve tissue revealed that Sephin1 treatment enhanced key downstream indicators of the integrated stress response pathway. Sephin1-treated nerves exhibited increased phosphorylation of eukaryotic translation initiation factor 2 alpha, which represents the core initiating event of the integrated stress response. In parallel, treated tissues displayed elevated transcript levels of the integrated stress response target gene Ddit3, accompanied by an increased presence of cleaved caspase-3-positive cells relative to complete Freund’s adjuvant controls.

Despite the structural and functional protections observed when treatment spanned the prophylactic-to-peak phase, initiating Sephin1 at clinical symptom onset failed to confer lasting protection. Neither continuous onset-initiated administration through chronic disease nor a short seven-day course preserved visual acuity in chronic stages. Furthermore, continuous therapeutic treatment from onset did not maintain chronic retinal ganglion cell populations, indicating that enhancing the integrated stress response as a standalone therapy possesses a constrained therapeutic window in experimental visual pathway injury.

Subject of Research: Visual circuit protection and myelin preservation by Sephin1 in experimental autoimmune encephalomyelitis

Article Title: Sephin1 protects visual circuit function and structural integrity through myelin preservation during experimental autoimmune encephalomyelitis

Article References: Mey, G. M., Classe, M. J., Staples, J. N., Chen, Y., & Werneburg, S. (2026). Sephin1 protects visual circuit function and structural integrity through myelin preservation during experimental autoimmune encephalomyelitis. Acta Neuropathologica Communications. https://doi.org/10.1186/s40478-026-02488-4

Image Credits: AI Generated

DOI: 10.1186/s40478-026-02488-4

Keywords: multiple sclerosis, experimental autoimmune encephalomyelitis, Sephin1, integrated stress response, visual pathway, optomotor response, visual evoked potentials, pattern electroretinography, retinal ganglion cells, optic nerve, lateral geniculate nucleus, myelin preservation, oligodendrocytes, axonal protection, neurodegeneration, demyelination, eIF2alpha phosphorylation, Ddit3

News Source: Ophelia Keating. (November 20, 2026). Prophylactic Sephin1 Preserves Mouse Visual Circuit Structure and Function in Autoimmune Encephalomyelitis. Scienmag.

Tags: axonal protectionDDIT3demyelinationeIF2alpha phosphorylationexperimental autoimmune encephalomyelitisintegrated stress responselateral geniculate nucleusMultiple Sclerosismyelin preservationneurodegenerationoligodendrocytesoptic nerveoptomotor responsepattern electroretinographyRetinal ganglion cellsSephin1visual evoked potentialsvisual pathway
Share12Tweet7Share2ShareShareShare1

Related Posts

Modulating Innate Immune Lipid Metabolism May Enhance Breast Cancer Immunotherapy Response

Modulating Innate Immune Lipid Metabolism May Enhance Breast Cancer Immunotherapy Response

November 20, 2026
Healthy Food Basket Demands Nearly Entire Minimum Wage in Low-Income Lima

Healthy Food Basket Demands Nearly Entire Minimum Wage in Low-Income Lima

November 20, 2026

Scheduled Acetaminophen Protocol Lowers Opioid Use After Median Sternotomy Cardiac Surgery

November 20, 2026

Narrative Review Assesses Digital Technologies and Systemic Hurdles in Geriatric Care

November 20, 2026

POPULAR NEWS

  • Hybrid PET-MRI Motion Correction Enables High-Resolution Cardiac Disease Quantification

    Hybrid PET-MRI Motion Correction Enables High-Resolution Cardiac Disease Quantification

    29 shares
    Share 12 Tweet 7
  • Microbiota Shifts Interact With Host Methylation and TP53 Mutations in Gastric Cancer

    29 shares
    Share 12 Tweet 7
  • Cardiac Imaging Links Heart Markers to Quality of Life in DMD Carriers

    29 shares
    Share 12 Tweet 7
  • Study Links 18p Chromosomal Deletions to Reproductive and Endocrine Anomalies

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Resource Depth Matching Algorithm Optimizes Task Scheduling in Heterogeneous Distributed Systems

Modulating Innate Immune Lipid Metabolism May Enhance Breast Cancer Immunotherapy Response

Pathway-Dependent Reactive Oxygen Species Accelerate Genetic Instability and Production Loss in Bacteria

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.